FDA Grants Breakthrough Therapy Designation to Cannabis-Derived Drug for Chronic Back Pain
The U.S. Food and Drug Administration (FDA) last month granted Breakthrough Therapy Designation to VER-01, a cannabis-derived, full-spectrum drug for chronic lo...